In addition to known oncogenic mutations in PIK3CA, recent cancer genome sequencing efforts have identified recurrent somatic mutations of PIK3R1 in GBM, endometrial, and colon cancers [2], [3], [9], [10]. This evidence concerns the gene PIK3R1 and malignant colon neoplasm.